39 recruiting, 9 completed, 9 unknown, 7 active not recruiting. 23 Not applicable, 19 Phase 2, 9 Phase 3, 1 Phase 1, 1 Phase 4.
Follow Tata Memorial Centre: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRINITY TRIAL; Trial Of PRRT Plus CAPTEM Vs CAPTEM Alone In Well Differentiated GEP NETS Capecitabine, Temozolomide (TMZ), Lutetium Lu 177 Dotatate - Gastroenteropancreatic Neuroendocrine Tumors | Phase 3 | Not yet recruiting | Tata Memorial Hospital | 123 | 2026-10-11 | 2026-11-02 |
| A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract Bleeding Chlorophyllin, Sodium Copper Complex, Placebo - Radiation Proctitis, Gastrointestinal Hemorrhage | Phase 3 | Not yet recruiting | Tata Memorial Centre | 200 | 2026-09-15 | 2026-09-23 |
| Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow Adaptive radiotherapy - Diffuse Glioma, Glioblastoma | Phase 2 | Recruiting | Tata Memorial Centre | 60 | 2026-07-27 | 2026-08-17 |
| Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors Neurological assessment - CNS Tumor, Artificial Intelligence (AI) | Recruiting | Tata Memorial Centre | 600 | 2026-02-20 | 2026-02-24 | |
| BIO-SHORT: Hypofractionated RT for Poor-Prognosis GBM Standard radiotherapy using hypofractionated RT, Experimental Arm Intervention - Glioma | Not applicable | Recruiting | Tata Memorial Centre | 108 | 2025-11-06 | 2026-05-18 |
| Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple Myeloma Daratumumab (Intravenously), Bortezomib (BTZ), Len (lenalidomide) - Newly Diagnosed Multiple Myeloma (NDMM) | Phase 2 | Recruiting | Tata Memorial Centre | 52 | 2025-10-28 | 2026-10-27 |
| Phase II Trial of Immunonutrition in Hepatectomy Immunonutrition - Hepatocellular Carcinoma, ASA I-III Patients | Not applicable | Recruiting | Tata Memorial Centre | 100 | 2025-10-03 | 2026-02-09 |
| Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT) Intensity-modulated proton therapy (IMPT), Photon-based intensity-modulated radiation therapy (IMRT). - Brain Tumor, Pediatric | Not applicable | Recruiting | Tata Memorial Centre | 94 | 2025-08-07 | 2026-01-30 |
| Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors Proton Beam Therapy, Photon Radiotherapy - Primary Brain Tumors, Diffuse Glioma | Not applicable | Recruiting | Tata Memorial Centre | 156 | 2025-07-01 | 2025-09-16 |
| Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative Sentinel Node Biopsy, Limited Elective Neck Dissection - Mouth Neoplasms, Oral Cancers | Not applicable | Recruiting | Tata Memorial Hospital | 508 | 2025-04-16 | 2025-07-17 |
| To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers Cyclophosphamide - Haploidentical Hematopoietic Stem Cell Transplant, Hematological Malignancies | Phase 2 | Recruiting | Tata Memorial Centre | 20 | 2025-03-26 | 2026-07-22 |
| IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer IMPT (Intensity Modulated Proton Therapy), IMRT (Intensity Modulated Radiation Therapy) - Malignant Neoplasm of Anal Canal | Not applicable | Recruiting | Tata Memorial Centre | 108 | 2025-03-18 | 2025-04-08 |
| Delphi Process to Achieve Global Consensus on Gender Equity in Critical Care Survey - Professional Role, Research Peer Review | Not yet recruiting | Tata Memorial Centre | 45 | 2025-03-01 | 2025-02-26 | |
| Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial ADT for 9 months and ARTA for 6 months, ADT for 2 years - Prostate Carcinoma | Phase 2 | Recruiting | Tata Memorial Centre | 206 | 2025-02-17 | 2025-02-21 |
| Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline Brain Tumors, Medulloblastoma | Recruiting | Tata Memorial Centre | 200 | 2025-02-11 | 2025-04-11 | |
| Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients SWA (standardized root extract of Withania somnifera) - Hematopoietic Stem Cell Transplant (HSCT), GVHD - Graft-Versus-Host Disease | Phase 1 / Phase 2 | Recruiting | Tata Memorial Centre | 54 | 2025-01-28 | 2026-07-24 |
| Tracing Brain Tumors Through Deep Time Imaging with CT and MRI - Brain Tumor, Oncology | Recruiting | Tata Memorial Centre | 10000 | 2025-01-10 | 2025-04-11 | |
| Craniospinal Irradiation in Histone AlteRed Midline Glioma craniospinal irradiation - Glioma | Not applicable | Recruiting | Tata Memorial Centre | 32 | 2025-01-03 | 2025-01-20 |
| Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant Sodium Copper Chlorophyllin - Oral Mucositis, Total Body Irradiation | Phase 2 | Recruiting | Tata Memorial Centre | 17 | 2024-10-30 | 2026-07-27 |
| Asian Watch-and-Wait Database (AWWD) Rectal Adenocarcinoma, Rectal Cancer | Recruiting | Tata Memorial Centre | 337 | 2024-10-22 | 2024-11-20 |
Showing 20 of 73. Sign in to see all of them.
Brain Neoplasms (7) · Glioma (7) · Uterine Cervical Neoplasms (6) · Hematologic Neoplasms (5) · Breast Neoplasms (4) · Biliary Tract Neoplasms (3) · Central Nervous System Neoplasms (3) · Pain (3) · Prostatic Neoplasms (3) · Rectal Neoplasms (3) · Stomatitis (3) · Bronchiolitis Obliterans Syndrome (2) · Gallbladder Neoplasms (2) · Glioblastoma (2) · Graft vs Host Disease (2)
chlorophyllin (5) · Cisplatin (3) · Radiotherapy (3) · Radiotherapy, Intensity-Modulated (3) · 130-nm albumin-bound paclitaxel (2) · Craniospinal Irradiation (2) · Drug Therapy (2) · Gemcitabine (2) · Leflunomide (2) · Magnetic Resonance Imaging (2) · daratumumab (2) · Analgesics, Opioid (1) · Androgen Antagonists (1) · Atracurium (1) · Bevacizumab (1)
India (66) · South Africa (2) · Argentina (1) · Austria (1) · Cuba (1) · Indonesia (1) · Jordan (1) · Malaysia (1) · Netherlands (1) · Pakistan (1) · Philippines (1) · Thailand (1) · Uruguay (1)
Archya Dasgupta (2) · Navin Khattry, MD, DM (2) · Abhishek Chatterjee, MD (1) · Ankita Lapalikar, MBBS (1) · Anuja Bidkar (1) · Anuja Bidkar, DNBAnes (1) · Aparna Chatterjee, MDAnes (1) · Archya Dasgupta, MD (1) · Ashwini Budrukkar, MD, DNB (1) · Deepa Nair, MS(ENT),DNB (1) · Dr Shailesh V Shrikhande, MBBS MS MD (1) · Dr. Anant Gokarn, Gokarn (1)
PMID 19282026, PMID 23802653, PMID 26308596, PMID 26408225, PMID 30904387, PMID 32160294, PMID 32416453, PMID 35435039, PMID 5449164, PMID 10506676, PMID 10515382, PMID 10524421, PMID 10573044, PMID 10630287, PMID 10845900, PMID 10974628, PMID 11013273, PMID 11157015, PMID 11255204, PMID 11301861, PMID 11448365, PMID 11579339, PMID 11719388, PMID 11939602, PMID 11985515, PMID 12007937, PMID 12117328, PMID 12127688, PMID 12171484, PMID 12620949, PMID 12659416, PMID 12663454, PMID 12692611, PMID 12748973, PMID 12773983, PMID 12838028, PMID 13411920, PMID 13677497, PMID 14113077, PMID 14570648, PMID 14581426, PMID 14645636, PMID 14663780, PMID 14801776, PMID 15010067, PMID 15054456, PMID 15064010, PMID 15110092, PMID 15188447, PMID 15308095
U01CA269143 (1)